miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review.
NASH
biliary tract cancer
bladder cancer
breast cancer
cancer
cervical cancer
demyelinating diseases
endometrial cancer
gastrointestinal cancer
glioblastoma
gynecological cancers
hematological diseases
hepatocellular carcinoma
lung cancer
melanoma
miR
miR therapeutics
miR-221
miR-221/222
miRs
microRNA
myeloma
neuropathy
ovarian cancer
pancreatic cancer
pharmacokinetics
prostate cancer
renal cell carcinoma
sarcomas
solid cancers
urogenital cancer
Journal
Molecular therapy. Nucleic acids
ISSN: 2162-2531
Titre abrégé: Mol Ther Nucleic Acids
Pays: United States
ID NLM: 101581621
Informations de publication
Date de publication:
08 Mar 2022
08 Mar 2022
Historique:
entrez:
14
3
2022
pubmed:
15
3
2022
medline:
15
3
2022
Statut:
epublish
Résumé
Among deregulated microRNAs (miRs) in human malignancies, miR-221 has been widely investigated for its oncogenic role and as a promising biomarker. Moreover, recent evidence suggests miR-221 as a fine-tuner of chronic liver injury and inflammation-related events. Available information also supports the potential of miR-221 silencing as promising therapeutic intervention. In this systematic review, we selected papers from the principal databases (PubMed, MedLine, Medscape, ASCO, ESMO) between January 2012 and December 2020, using the keywords "miR-221" and the specific keywords related to the most important hematologic and solid malignancies, and some non-malignant diseases, to define and characterize deregulated miR-221 as a valuable therapeutic target in the modern vision of molecular medicine. We found a major role of miR-221 in this view.
Identifiants
pubmed: 35282417
doi: 10.1016/j.omtn.2022.02.005
pii: S2162-2531(22)00033-6
pmc: PMC8891816
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1191-1224Informations de copyright
© 2022 The Authors.
Déclaration de conflit d'intérêts
The authors declare no competing interests.
Références
PLoS One. 2014 Feb 27;9(2):e90005
pubmed: 24587182
Br J Cancer. 2020 May;122(11):1630-1637
pubmed: 32238921
Mol Cell Biochem. 2019 Oct;460(1-2):37-51
pubmed: 31222560
Oncogene. 2016 Mar 10;35(10):1302-1313
pubmed: 26028030
J Surg Oncol. 2013 Apr;107(5):505-10
pubmed: 22996433
Cell Cycle. 2014;13(11):1811-26
pubmed: 24736554
Gene. 2019 Aug 30;711:143938
pubmed: 31220580
Oncogene. 2012 Feb 16;31(7):858-68
pubmed: 21743492
N Engl J Med. 2013 Dec 12;369(24):2324-31
pubmed: 24328466
Genes Chromosomes Cancer. 2010 Jul;49(7):577-84
pubmed: 20461750
Curr Pharm Des. 2013;19(7):1273-84
pubmed: 23092346
Med Oncol. 2013 Mar;30(1):452
pubmed: 23307259
Clin Cancer Res. 2012 Nov 15;18(22):6260-70
pubmed: 23035210
JCI Insight. 2016 Jul 7;1(10):e86051
pubmed: 27699216
Ann Surg. 2016 Nov;264(5):804-814
pubmed: 27501171
Int J Mol Sci. 2020 Sep 30;21(19):
pubmed: 33007856
Mol Ther Nucleic Acids. 2016 Jun 21;5(6):
pubmed: 27327137
Cancer Gene Ther. 2014 Jul;21(7):290-6
pubmed: 24924200
Int J Cancer. 2020 Nov 15;147(10):2934-2947
pubmed: 32441313
Acta Neurochir (Wien). 2020 May;162(5):1187-1195
pubmed: 32016588
Mol Cancer. 2011 Apr 18;10:41
pubmed: 21501493
Science. 1991 Dec 6;254(5037):1497-500
pubmed: 1962210
Adv Drug Deliv Rev. 2015 Jun 29;87:46-51
pubmed: 25666165
Int J Mol Med. 2015 Nov;36(5):1377-83
pubmed: 26397386
Biochem Pharmacol. 1994 Sep 15;48(6):1310-3
pubmed: 7945427
J Int Med Res. 2012;40(2):467-74
pubmed: 22613407
J Int Med Res. 2013 Feb;41(1):64-71
pubmed: 23569131
Int J Cancer. 2013 Jun 15;132(12):2867-75
pubmed: 23184647
Cancers (Basel). 2020 Dec 14;12(12):
pubmed: 33327491
Tumour Biol. 2016 Oct 10;:
pubmed: 27726102
EJIFCC. 2019 Jun 24;30(2):114-127
pubmed: 31263388
Mol Cancer Ther. 2016 Jun;15(6):1387-96
pubmed: 26883272
Blood Cancer J. 2016 Mar 18;6:e406
pubmed: 26990535
Cancer Res. 2011 Dec 15;71(24):7608-16
pubmed: 22009537
Nat Rev Mol Cell Biol. 2019 Jan;20(1):5-20
pubmed: 30228348
Dig Dis Sci. 2016 May;61(5):1304-13
pubmed: 26725058
Mech Ageing Dev. 2016 Jul;157:17-29
pubmed: 27393639
Curr Opin Mol Ther. 2010 Dec;12(6):695-702
pubmed: 21154161
Cytotechnology. 2018 Feb;70(1):203-213
pubmed: 28887606
Cancer Lett. 2017 Feb 28;387:84-94
pubmed: 27045478
Am J Transl Res. 2016 Nov 15;8(11):4764-4777
pubmed: 27904678
PLoS One. 2015 Apr 24;10(4):e0103258
pubmed: 25909813
Med Sci Monit. 2014 Nov 28;20:2472-7
pubmed: 25430553
Eur J Pharmacol. 2020 Nov 5;886:173509
pubmed: 32889065
Oncogene. 2018 Apr;37(15):1991-2007
pubmed: 29367756
Int J Biol Markers. 2019 Jun;34(2):184-193
pubmed: 31084400
Mol Oncol. 2015 Aug;9(7):1421-33
pubmed: 25898773
Expert Opin Drug Metab Toxicol. 2009 Apr;5(4):381-91
pubmed: 19379126
BMB Rep. 2014 May;47(5):268-73
pubmed: 24286315
Iran Biomed J. 2015;19(4):188-93
pubmed: 26209976
Cancers (Basel). 2019 Dec 19;12(1):
pubmed: 31861748
J Pharm Biomed Anal. 2018 Feb 20;150:300-307
pubmed: 29268195
Crit Rev Oncol Hematol. 2017 Aug;116:11-31
pubmed: 28693792
BMC Cancer. 2010 Jul 12;10:367
pubmed: 20618998
Cancer Res. 2014 May 1;74(9):2591-603
pubmed: 24607843
Epigenetics. 2019 Jun;14(6):545-557
pubmed: 30983504
J Mol Neurosci. 2021 Apr;71(4):836-844
pubmed: 32989634
Pathobiology. 2021;88(4):289-300
pubmed: 34130294
Drug Res (Stuttg). 2017 Sep;67(9):509-514
pubmed: 28628924
Oncotarget. 2017 Jan 24;8(4):6513-6525
pubmed: 28036284
Med Oncol. 2012 Jun;29(2):815-22
pubmed: 21487968
Neuroscience. 2018 May 21;379:239-245
pubmed: 29577996
Anticancer Res. 2015 Feb;35(2):1091-7
pubmed: 25667498
Clin Hemorheol Microcirc. 2020;76(3):425-437
pubmed: 32804119
Diagn Pathol. 2021 May 22;16(1):46
pubmed: 34022918
J Cancer Res Clin Oncol. 2012 Oct;138(10):1641-50
pubmed: 22618509
Mol Cell. 2016 Oct 20;64(2):320-333
pubmed: 27720646
Front Oncol. 2020 May 12;10:589
pubmed: 32477928
Biochemistry (Mosc). 2015 Mar;80(3):276-83
pubmed: 25761682
J Clin Med. 2020 Mar 02;9(3):
pubmed: 32131507
Mol Ther Nucleic Acids. 2020 Mar 6;19:1434-1448
pubmed: 32160712
Cancer Manag Res. 2020 May 25;12:3845-3850
pubmed: 32547220
BMC Cancer. 2019 Jun 25;19(1):627
pubmed: 31238903
PLoS One. 2015 Oct 26;10(10):e0141168
pubmed: 26501139
Med Sci (Basel). 2020 Mar 13;8(1):
pubmed: 32183076
RNA. 2019 Jan;25(1):1-16
pubmed: 30333195
J Natl Cancer Inst. 2010 May 19;102(10):706-21
pubmed: 20388878
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Br J Cancer. 2015 Sep 29;113(7):1055-65
pubmed: 26325107
Eur Rev Med Pharmacol Sci. 2019 Aug;23(16):6983-6990
pubmed: 31486498
Expert Opin Ther Targets. 2016 Sep;20(9):1099-108
pubmed: 26959615
Oncol Rep. 2012 May;27(5):1504-10
pubmed: 22294051
Cancers (Basel). 2020 Mar 17;12(3):
pubmed: 32192047
PLoS One. 2015 May 08;10(5):e0125779
pubmed: 25955843
PLoS One. 2015 Sep 22;10(9):e0138383
pubmed: 26394310
Molecules. 2014 May 30;19(6):7122-37
pubmed: 24886939
PLoS One. 2013 Jun 11;8(6):e65868
pubmed: 23776562
Urol Oncol. 2016 Dec;34(12):533.e21-533.e27
pubmed: 27427222
Life Sci. 2021 Feb 15;267:118928
pubmed: 33358902
J Neurooncol. 2019 Sep;144(3):545-551
pubmed: 31422498
Andrologia. 2019 Nov;51(10):e13384
pubmed: 31483058
Sci Rep. 2020 Jan 14;10(1):227
pubmed: 31937854
Cancer Biomark. 2017;18(2):209-214
pubmed: 27983537
Int J Oncol. 2017 Apr;50(4):1087-1096
pubmed: 28350128
Exp Hematol Oncol. 2013 Apr 08;2(1):10
pubmed: 23566596
J Neurooncol. 2017 Jan;131(2):255-265
pubmed: 27837435
PLoS One. 2017 Sep 8;12(9):e0184166
pubmed: 28886115
Int J Mol Sci. 2020 Jan 09;21(2):
pubmed: 31936594
PLoS One. 2015 Oct 20;10(10):e0140862
pubmed: 26484677
Adv Drug Deliv Rev. 2015 Jun 29;87:3-14
pubmed: 25979468
Cancer Med. 2020 Feb;9(4):1544-1552
pubmed: 31899608
Oncogene. 2019 Feb;38(8):1256-1268
pubmed: 30254211
Mol Carcinog. 2013 Apr;52(4):297-303
pubmed: 22213236
Genes Chromosomes Cancer. 2018 Mar;57(3):150-161
pubmed: 29181884
Biochem Biophys Res Commun. 2011 Mar 4;406(1):70-3
pubmed: 21295551
Oncogene. 2014 May 22;33(21):2790-800
pubmed: 23770851
Am J Transl Res. 2021 Jul 15;13(7):7524-7537
pubmed: 34377233
Anticancer Res. 2018 May;38(5):2961-2965
pubmed: 29715124
Thromb Res. 2016 Jan;137:126-140
pubmed: 26632513
Ann Oncol. 2013 Oct;24(10):2534-2542
pubmed: 23729783
Arch Dermatol Res. 2017 Dec;309(10):823-831
pubmed: 28936555
J Clin Med. 2015 Aug 06;4(8):1566-77
pubmed: 26258795
Clin Cancer Res. 2013 Apr 15;19(8):2187-96
pubmed: 23444217
Front Oncol. 2020 Dec 04;10:543817
pubmed: 33344224
Clin Cancer Res. 2016 Mar 1;22(5):1222-33
pubmed: 26527748
Biomed Res Int. 2014;2014:217365
pubmed: 24683542
Biochem Biophys Res Commun. 2018 Mar 18;497(4):1162-1170
pubmed: 28057486
Oncogene. 2016 May 5;35(18):2345-56
pubmed: 26364608
J Biol Chem. 2019 Sep 13;294(37):13681-13696
pubmed: 31341019
Tumour Biol. 2016 Apr;37(4):4509-15
pubmed: 26503209
Aging (Albany NY). 2019 Sep 18;11(18):7553-7569
pubmed: 31532756
Parkinsonism Relat Disord. 2016 Dec;33:115-121
pubmed: 27717584
Anticancer Res. 2019 Oct;39(10):5311-5327
pubmed: 31570425
Eur Rev Med Pharmacol Sci. 2016 Apr;20(8):1509-15
pubmed: 27160122
Oncotarget. 2015 Jun 10;6(16):14153-64
pubmed: 25883224
Cancer Biomark. 2018;22(2):283-299
pubmed: 29630521
Hepatology. 2012 Sep;56(3):1025-33
pubmed: 22473819
J Cancer. 2017 Jan 1;8(1):48-56
pubmed: 28123597
Hum Pathol. 2011 Oct;42(10):1391-400
pubmed: 21458843
Int J Cardiol. 2017 Dec 15;249:402-409
pubmed: 29121743
Curr Pharm Biotechnol. 2014;15(5):459-67
pubmed: 24846067
Chem Commun (Camb). 2013 Jun 25;49(50):5618-20
pubmed: 23682352
BMC Syst Biol. 2016 Jan 11;10 Suppl 1:1
pubmed: 26817819
Sci Signal. 2011 Jun 14;4(177):ra41
pubmed: 21673316
PLoS One. 2016 Sep 29;11(9):e0163699
pubmed: 27685844
Cancer Gene Ther. 2021 Jun;28(6):679-692
pubmed: 33214694
Genes Chromosomes Cancer. 2013 Apr;52(4):356-69
pubmed: 23404859
EBioMedicine. 2018 Nov;37:7-8
pubmed: 30344123
Oncogene. 2008 Sep 25;27(43):5651-61
pubmed: 18521080
Semin Liver Dis. 2015 Feb;35(1):12-25
pubmed: 25632931
Int Immunopharmacol. 2019 Oct;75:105783
pubmed: 31376622
J Biol Chem. 2012 May 4;287(19):15672-83
pubmed: 22431733
Viruses. 2019 Nov 30;11(12):
pubmed: 31801280
Curr Pharm Biotechnol. 2018;19(13):1076-1086
pubmed: 30417784
Neoplasma. 2010;57(3):264-9
pubmed: 20353279
Gastroenterology. 2013 Dec;145(6):1300-11
pubmed: 23933602
Cells. 2020 Jul 23;9(8):
pubmed: 32717951
Biomaterials. 2018 Jun;167:80-90
pubmed: 29554483
J Cell Sci. 2012 Jun 1;125(Pt 11):2675-83
pubmed: 22393241
Cancer Res. 2015 Oct 15;75(20):4384-4397
pubmed: 26249174
Cancer Cell. 2014 Nov 10;26(5):707-21
pubmed: 25446899
Lancet. 2013 Sep 7;382(9895):889-99
pubmed: 23618600
Noncoding RNA. 2020 May 11;6(2):
pubmed: 32403384
Front Endocrinol (Lausanne). 2018 Aug 03;9:402
pubmed: 30123182
Br J Haematol. 2018 Nov;183(3):428-444
pubmed: 30125933
Onco Targets Ther. 2017 Aug 22;10:4161-4171
pubmed: 28860826
Biomed Res Int. 2019 Nov 14;2019:6392748
pubmed: 31828111
Oncol Lett. 2013 May;5(5):1639-1642
pubmed: 23761828
Br J Cancer. 2014 Mar 4;110(5):1199-210
pubmed: 24473397
Tumour Biol. 2016 Sep;37(9):12273-12286
pubmed: 27271989
J Cell Biochem. 2017 Dec;118(12):4772-4781
pubmed: 28519068
J Cell Physiol. 2019 Apr;234(4):3500-3514
pubmed: 30370582
Infect Genet Evol. 2017 Jul;51:173-181
pubmed: 28366737
Eur J Pharmacol. 2019 Jun 15;853:353-363
pubmed: 30928631
BMC Urol. 2015 Apr 28;15:36
pubmed: 25928257
Nat Commun. 2017 Oct 6;8(1):797
pubmed: 28986522
Mol Cell Probes. 2019 Oct;47:101442
pubmed: 31479716
J Control Release. 2021 May 10;333:28-40
pubmed: 33741386
Nat Rev Drug Discov. 2012 Jan 20;11(2):125-40
pubmed: 22262036
Nucleic Acids Res. 1995 Jun 11;23(11):2019-24
pubmed: 7541132
High Throughput. 2018 Oct 26;7(4):
pubmed: 30373182
Int J Mol Sci. 2014 May 27;15(6):9360-71
pubmed: 24871365
Int J Mol Sci. 2020 Jul 23;21(15):
pubmed: 32718068
Radiother Oncol. 2014 Dec;113(3):379-84
pubmed: 25466375
J Exp Clin Cancer Res. 2020 Jun 20;39(1):117
pubmed: 32563270
Expert Opin Ther Pat. 2014 Mar;24(3):267-94
pubmed: 24405414
N Engl J Med. 2020 May 14;382(20):1894-1905
pubmed: 32402160
Mol Ther. 2015 Nov;23(11):1748-1758
pubmed: 26201448
Oncol Rep. 2019 Mar;41(3):1439-1454
pubmed: 30628706
Lancet. 2017 Feb 18;389(10070):709-717
pubmed: 28087069
Cell Cycle. 2015;14(4):481-7
pubmed: 25607528
Tumour Biol. 2017 Nov;39(11):1010428317726842
pubmed: 29110584
Pharmacogenomics. 2017 Sep;18(14):1343-1358
pubmed: 28832247
Clin Cancer Res. 2013 Apr 15;19(8):2096-106
pubmed: 23446999
Arch Toxicol. 2016 Oct;90(10):2405-19
pubmed: 27557899
Biomed Pharmacother. 2015 Oct;75:153-8
pubmed: 26422796
J Oncol. 2019 Dec 24;2019:7252013
pubmed: 31929798
Int J Nanomedicine. 2018 Apr 13;13:2295-2307
pubmed: 29713162
Ann Oncol. 2014 Sep;25 Suppl 3:iii93-101
pubmed: 24782454
Methods Mol Biol. 2016;1375:181-94
pubmed: 25971914
PLoS One. 2014 Jun 06;9(6):e99067
pubmed: 24905916
J Neurooncol. 2013 May;112(3):347-54
pubmed: 23420397
Hepatol Int. 2019 May;13(3):277-292
pubmed: 31069760
Mol Med Rep. 2019 Jul;20(1):604-612
pubmed: 31180541
Blood. 2012 Jan 19;119(3):e9-e21
pubmed: 22110251
Int J Cancer. 2010 Jul 15;127(2):394-403
pubmed: 19585579
Eur Rev Med Pharmacol Sci. 2019 May;23(9):3645-3653
pubmed: 31114989
Onco Targets Ther. 2019 Oct 23;12:8725-8736
pubmed: 31695430
Br J Cancer. 2011 Jun 28;105(1):104-11
pubmed: 21673684
Anticancer Res. 2020 Jun;40(6):3265-3270
pubmed: 32487621
Oncol Lett. 2020 Sep;20(3):2962-2968
pubmed: 32782613
Eur Rev Med Pharmacol Sci. 2019 May;23(10):4226-4233
pubmed: 31173294
Adv Cancer Res. 2017;135:1-24
pubmed: 28882219
PLoS One. 2013;8(1):e53906
pubmed: 23372675
BMC Urol. 2018 Mar 5;18(1):14
pubmed: 29506516
Sci Signal. 2014 Jul 01;7(332):ra63
pubmed: 24985346
Int J Cardiol. 2019 Sep 15;291:158-167
pubmed: 31151766
Diabetologia. 2013 Sep;56(9):1971-9
pubmed: 23756832
Neuropathology. 2014 Oct;34(5):455-64
pubmed: 24780067
Am J Clin Pathol. 2018 Mar 29;149(5):412-417
pubmed: 29538610
Prostate. 2019 Jul;79(10):1125-1132
pubmed: 31045265
Mol Oncol. 2014 Mar;8(2):417-30
pubmed: 24412053
J Cell Biochem. 2019 Mar;120(3):4665-4674
pubmed: 30582227
Cell Death Dis. 2017 Dec 14;8(12):3220
pubmed: 29242498
Mol Cancer. 2019 Jun 22;18(1):110
pubmed: 31228940
Biosci Rep. 2018 Dec 11;38(6):
pubmed: 30473536
Oncol Lett. 2018 Nov;16(5):6697-6704
pubmed: 30405811
Clin Cancer Res. 2017 Jul 15;23(14):3953-3965
pubmed: 28096271
Med Sci Monit. 2015 Sep 13;21:2718-25
pubmed: 26364844
Nat Rev Mol Cell Biol. 2014 Aug;15(8):509-24
pubmed: 25027649
Lancet. 2015 Apr 11;385(9976):1447-59
pubmed: 25484026
Tumour Biol. 2014 May;35(5):4057-66
pubmed: 24379138
Expert Opin Biol Ther. 2013 Jun;13 Suppl 1:S125-37
pubmed: 23692413
Onco Targets Ther. 2020 Apr 05;13:2925-2934
pubmed: 32308425
Eur Rev Med Pharmacol Sci. 2018 May;22(10):3094-3117
pubmed: 29863255
Cancers (Basel). 2018 Oct 30;10(11):
pubmed: 30380719
Lab Med. 2019 Oct 10;50(4):333-347
pubmed: 31049571
Gene. 2017 Jul 15;620:46-53
pubmed: 28392366
Oncotarget. 2015 Apr 10;6(10):8103-14
pubmed: 25797271
Sci Rep. 2020 Oct 20;10(1):17768
pubmed: 33082482
Front Cell Neurosci. 2015 Dec 17;9:476
pubmed: 26733805
Oncotarget. 2013 Feb;4(2):242-55
pubmed: 23479461
Methods Mol Biol. 2015;1317:137-51
pubmed: 26072406
Curr Pharm Des. 2017;23(23):3440-3444
pubmed: 28067164
Mol Oncol. 2018 Jan;12(1):114-131
pubmed: 29120535
Leuk Lymphoma. 2019 Jul;60(7):1709-1720
pubmed: 30516071
Cancer Treat Rev. 2005 Nov;31(7):536-45
pubmed: 16236454
Curr Mol Med. 2014 Jan;14(1):185-95
pubmed: 24295494
Mol Ther Nucleic Acids. 2018 Dec 7;13:472-482
pubmed: 30388621
PLoS One. 2013 Oct 17;8(10):e77623
pubmed: 24147037
PLoS One. 2013 Jun 11;8(6):e66502
pubmed: 23776679
Methods Mol Biol. 2021;2211:123-143
pubmed: 33336275
Tumour Biol. 2017 Jun;39(6):1010428317701636
pubmed: 28618968
PLoS One. 2021 Mar 17;16(3):e0247550
pubmed: 33730072
Gene. 2015 Nov 10;572(2):252-8
pubmed: 26164758
Pharmacogenomics. 2019 Sep;20(14):1049-1059
pubmed: 31559917
Nucleic Acid Ther. 2014 Dec;24(6):374-87
pubmed: 25353652
Invest New Drugs. 2017 Apr;35(2):180-188
pubmed: 27917453
EBioMedicine. 2018 Nov;37:307-321
pubmed: 30316865
Toxicology. 2015 Jul 3;333:45-52
pubmed: 25846647
BMC Med Genomics. 2020 Sep 18;13(Suppl 8):129
pubmed: 32948204
Cancer Res. 2017 Apr 15;77(8):1927-1941
pubmed: 28202520
Genes Dev. 2010 Aug 1;24(15):1634-44
pubmed: 20624852
Front Genet. 2019 Oct 09;10:950
pubmed: 31649728
Nature. 2018 Jul;559(7712):114-119
pubmed: 29950719
Biosci Rep. 2019 Jul 10;39(7):
pubmed: 31221814
Antioxid Redox Signal. 2013 Nov 1;19(13):1522-38
pubmed: 23477488
Gig Sanit. 1986 Oct;(10):22-5
pubmed: 3098631
Oncol Lett. 2014 Feb;7(2):541-547
pubmed: 24396484
Int J Cardiol. 2021 Mar 15;327:146-154
pubmed: 33212095
Int J Oncol. 2015 Mar;46(3):1169-80
pubmed: 25585941
N Engl J Med. 2013 May 2;368(18):1685-94
pubmed: 23534542
Oncotarget. 2015 Feb 28;6(6):3709-21
pubmed: 25686829
Mol Ther Nucleic Acids. 2020 Jun 5;20:73-85
pubmed: 32146420
Cancer Cell. 2009 Dec 8;16(6):498-509
pubmed: 19962668
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Oncotarget. 2017 Oct 11;8(61):103315-103326
pubmed: 29262564
J Hepatol. 2012 Jun;56(6):1384-91
pubmed: 22326465
Toxicol Appl Pharmacol. 2012 Jul 1;262(1):52-9
pubmed: 22561871
Mol Cancer Res. 2016 Oct;14(10):909-919
pubmed: 27358112
Int J Clin Exp Pathol. 2019 May 01;12(5):1518-1528
pubmed: 31933969
J Cell Physiol. 2019 Dec;234(12):22272-22284
pubmed: 31106423
Oncotarget. 2018 Apr 10;9(27):19136-19146
pubmed: 29721189
Oncogene. 2012 Feb 2;31(5):634-42
pubmed: 21706050
Biochem Biophys Res Commun. 2019 Jan 22;508(4):991-996
pubmed: 30551873
J Cancer. 2020 Jan 1;11(6):1383-1392
pubmed: 32047545
J Cancer. 2020 Apr 7;11(14):4106-4114
pubmed: 32368293
Toxicol In Vitro. 2016 Sep;35:180-7
pubmed: 27288564
Bioanalysis. 2019 Nov;11(21):1909-1912
pubmed: 31648523
Int J Cancer. 2013 Aug 15;133(4):879-92
pubmed: 23400877
PLoS One. 2014 Feb 21;9(2):e89659
pubmed: 24586944
Biomed Res Int. 2018 Jan 30;2018:7908950
pubmed: 29876362
Biochim Biophys Acta. 2015 Jan;1853(1):244-53
pubmed: 25447674
J Immunother Cancer. 2021 Feb;9(2):
pubmed: 33597219
Medicine (Baltimore). 2018 Jul;97(29):e11100
pubmed: 30024497
Oncotarget. 2017 Sep 23;8(49):85783-85793
pubmed: 29156756
Lung Cancer. 2017 Dec;114:6-11
pubmed: 29173767
Biomed Pharmacother. 2019 Nov;119:109406
pubmed: 31514066
Hepatology. 2013 Jan;57(1):299-310
pubmed: 22821679
PLoS One. 2013 Sep 19;8(9):e74466
pubmed: 24147153
PLoS One. 2014 Jun 03;9(6):e98833
pubmed: 24892674
Am J Cancer Res. 2013 Nov 01;3(5):465-77
pubmed: 24224124
Int J Clin Exp Pathol. 2015 May 01;8(5):5224-9
pubmed: 26191221
Nature. 1993 Oct 7;365(6446):490-2
pubmed: 8413600
Cancer Sci. 2011 Dec;102(12):2186-90
pubmed: 21895872
Oncol Lett. 2015 Oct;10(4):2269-2272
pubmed: 26622832
Leuk Res. 2013 Jun;37(6):647-56
pubmed: 23522449
Oncotarget. 2017 Mar 29;9(4):5473-5479
pubmed: 29435194
World J Hepatol. 2015 Apr 28;7(6):846-58
pubmed: 25937862
Arch Med Res. 2021 Feb;52(2):191-199
pubmed: 33131925
Cancer Res. 2014 Jan 1;74(1):363-373
pubmed: 24197133
Nat Rev Urol. 2014 Sep;11(9):517-25
pubmed: 25112856